Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P43026 (
lipopolysaccharide
)
62,215
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Macrophage activation is central to the progression of multiple diseases via the release of inflammatory mediators such as cytokines and nitric oxide. Despite the recognized overlap in the regulatory mechanisms involved in mediator production, little formation exists regarding receptor-initiated signaling pathways that coordinately control multiple end points, such as tumor necrosis factor-alpha (TNF-alpha) and nitric oxide production. In this study, the expression of inducible nitric oxide synthase (iNOS) in macrophages is shown to be regulated by calcium and by a
purinoreceptor
signaling system. The P2Y
purinoreceptor
partial agonist, 2-methylthio-ATP (2-MeS-ATP), inhibits the expression of iNOS induced by
lipopolysaccharide
(
LPS
) plus interferon-gamma (IFN-gamma) in primary macrophages. Additionally, 2-MeS-ATP attenuates the expression of iNOS in macrophages isolated from CD-1 mice challenged with
LPS
, and it inhibits
LPS
-induced TNF-alpha and interleukin-1 alpha (IL-1 alpha) release, thereby preventing endotoxic death. Thus, purinoreceptors and calcium are likely to be critical for macrophage activation and the production of inflammatory mediators stimulated by
LPS
.
...
PMID:Regulation of inducible nitric oxide synthase expression by macrophage purinoreceptors and calcium. 855 May 83
Cultured, proliferating microglial cells can be further activated by
lipopolysaccharide
(
LPS
) and, thereby, turned into a non-proliferating state. While proliferating cells exhibit only inwardly rectifying potassium channels, non-proliferating cells express, in addition, outwardly rectifying potassium channels. The characteristics of the two channel populations are markedly different. Inward potassium currents inactivate and can be abolished by extracellular Cs+ and Ba2+. Outward potassium currents only slightly inactivate and can be abolished by 4-aminopyridine, quinine and charybdotoxin. An increase in the intracellular free Ca2+ concentration depresses the outward potassium current. ATP or its structural analogues stimulate two types of P2-purinoceptors on microglial cells, a ligand-activated cationic channel (P2x) which produces depolarization and a G protein coupled receptor (P2Y) which produces hyper-polarization via the opening of K+ channels. Both
P2X
- and P2Y-receptor stimulation may increase the intracellular Ca2+ concentration. In the former case, Ca2+ enters the cells via non-selective cationic channels. In the latter case, Ca2+ may be released from intracellular stores, owing to activation of the enzyme phospholipase C and subsequent generation of inositol 1,4,5-trisphosphate (IP3). It is assumed that neuronal damage leads to efflux of ATP into the extracellular space with subsequent activation of microglia. ATP-induced excessive depolarizations by
P2X
-purinoceptor stimulation may be counteracted by outwardly rectifying potassium channels and by hyperpolarizing P2Y-purinoceptors in non-proliferating microglia.
...
PMID:Molecular mechanisms of microglial activation. B. Voltage- and purinoceptor-operated channels in microglia. 880 85
The effects of maitotoxin (MTX) on plasmalemma permeability are similar to those caused by stimulation of P2Z/
P2X
(7) ionotropic receptors, suggesting that 1) MTX directly activates P2Z/
P2X
(7) receptors or 2) MTX and P2Z/
P2X
(7) receptor stimulation activate a common cytolytic pore. To distinguish between these two possibilities, the effect of MTX was examined in 1) THP-1 monocytic cells before and after treatment with
lipopolysaccharide
and interferon-gamma, a maneuver known to upregulate P2Z/
P2X
(7) receptor, 2) wild-type HEK cells and HEK cells stably expressing the P2Z/
P2X
(7) receptor, and 3) BW5147.3 lymphoma cells, a cell line that expresses functional P2Z/
P2X
(7) channels that are poorly linked to pore formation. In control THP-1 monocytes, addition of MTX produced a biphasic increase in the cytosolic free Ca(2+) concentration ([Ca(2+)](i)); the initial increase reflects MTX-induced Ca(2+) influx, whereas the second phase correlates in time with the appearance of large pores and the uptake of ethidium. MTX produced comparable increases in [Ca(2+)](i) and ethidium uptake in THP-1 monocytes overexpressing the P2Z/
P2X
(7) receptor. In both wild-type HEK and HEK cells stably expressing the P2Z/
P2X
(7) receptor, MTX-induced increases in [Ca(2+)](i) and ethidium uptake were virtually identical. The response of BW5147.3 cells to concentrations of MTX that produced large increases in [Ca(2+)](i) had no effect on ethidium uptake. In both THP-1 and HEK cells, MTX- and Bz-ATP-induced pores activate with similar kinetics and exhibit similar size exclusion. Last, MTX-induced pore formation, but not channel activation, is greatly attenuated by reducing the temperature to 22 degrees C, a characteristic shared by the P2Z/
P2X
(7)-induced pore. Together, the results demonstrate that, although MTX activates channels that are distinct from those activated by P2Z/
P2X
(7) receptor stimulation, the cytolytic/oncotic pores activated by MTX- and Bz-ATP are indistinguishable.
...
PMID:Maitotoxin and P2Z/P2X(7) purinergic receptor stimulation activate a common cytolytic pore. 1051 7
Little is known about the mechanisms of
lipopolysaccharide
(
LPS
) signaling in immature cells that do not express the
LPS
receptor CD14 yet. Bone marrow granulocytes do not constitutively express CD14 but can be stimulated by low doses of
LPS
in the absence of serum and then express an inducible form of
LPS
receptor (iLpsR). We show that in addition to
LPS
, cholera toxin (CT) and various cyclic AMP (cAMP) analogs can also induce the expression of iLpsR, which was identified as CD14. Induction was independent of intracellular cAMP. The hypothesis that cAMP analogs act via a cell surface receptor was suggested by the unresponsiveness of trypsin-treated cells to these inducers and by the specific binding of [(3)H]cAMP to the cells. This binding was not inhibited by
LPS
or CT but was inhibited by various purine derivatives. However, the receptor involved is not a conventional
purinoreceptor
since both an agonist and an antagonist of such receptors were able to induce iLpsR expression. The results suggest that cAMP analogs and other purine derivatives induce iLpsR after interaction with an unconventional, trypsin-sensitive,
purinoreceptor
distinct from
LPS
and CT receptors.
...
PMID:Exogenous cyclic AMP, cholera toxin, and endotoxin induce expression of the lipopolysaccharide receptor CD14 in murine bone marrow cells: role of purinoreceptors. 1054 81
Murine P388D(1) macrophages exhibit a delayed prostaglandin biosynthetic response when exposed to bacterial
lipopolysaccharide
(
LPS
) for prolonged periods of time that is dependent on induction of the genes coding for Group V secretory phospholipase A(2) and cyclooxygenase-2. We herein report that
LPS
-induced arachidonic acid (AA) metabolite release in P388D(1) macrophages is strongly attenuated by the
P2X
(7) purinergic receptor antagonists periodate-oxidized ATP and pyridoxal-phosphate-6-azophenyl-2', 4'-disulfonic acid, and this is accompanied by suppression of the expression of both Group V secretory phospholipase A(2) and cyclooxygenase-2. The effect appears to be specific for
LPS
, because the P2 purinergic receptor antagonists do not affect P388D(1) cell stimulation by other stimuli such as platelet-activating factor or the Ca(2+) ionophore A23187. Moreover, extracellular nucleotides are found to stimulate macrophage AA mobilization with a pharmacological profile that implicates the participation of the
P2X
(7) receptor and that is inhibited by periodate-oxidized ATP. Collectively these results demonstrate coupling of the
P2X
(7) receptor to the AA cascade in P388D(1) macrophages and implicate the participation of this type of receptor in
LPS
-induced AA mobilization.
...
PMID:Regulation of arachidonic acid mobilization in lipopolysaccharide-activated P388D(1) macrophages by adenosine triphosphate. 1059 84
The
P2X
(7) receptor (
P2X
(7)R) is an ATP-gated ion channel expressed by monocytes and macrophages. To directly address the role of this receptor in interleukin (IL)-1 beta post-translational processing, we have generated a
P2X
(7)R-deficient mouse line.
P2X
(7)R(-/-) macrophages respond to
lipopolysaccharide
and produce levels of cyclooxygenase-2 and pro-IL-1 beta comparable with those generated by wild-type cells. In response to ATP, however, pro-IL-1 beta produced by the
P2X
(7)R(-/-) cells is not externalized or activated by caspase-1. Nigericin, an alternate secretion stimulus, promotes release of 17-kDa IL-1 beta from
P2X
(7)R(-/-) macrophages. In response to in vivo
lipopolysaccharide
injection, both wild-type and
P2X
(7)R(-/-) animals display increases in peritoneal lavage IL-6 levels but no detectable IL-1. Subsequent ATP injection to wild-type animals promotes an increase in IL-1, which in turn leads to additional IL-6 production; similar increases did not occur in ATP-treated, LPS-primed
P2X
(7)R(-/-) animals. Absence of the
P2X
(7)R thus leads to an inability of peritoneal macrophages to release IL-1 in response to ATP. As a result of the IL-1 deficiency, in vivo cytokine signaling cascades are impaired in
P2X
(7)R-deficient animals. Together these results demonstrate that
P2X
(7)R activation can provide a signal that leads to maturation and release of IL-1 beta and initiation of a cytokine cascade.
...
PMID:Altered cytokine production in mice lacking P2X(7) receptors. 1101 35
Interleukin (IL)-1beta and IL-18 are structurally similar proteins that require caspase-1 processing for activation. Both proteins are released from the cytosol by unknown pathway(s). To better characterize the release pathway(s) for IL-1beta and IL-18 we evaluated the role of
lipopolysaccharide
priming, of interleukin-1beta-converting enzyme (ICE) inhibition, of human purinergic receptor (
P2X
(7)) function, and of signaling pathways in human monocytes induced by ATP. Monocytes rapidly processed and released both IL-1beta and IL-18 after exogenous ATP. Despite its constitutive cytosolic presence, IL-18 required
lipopolysaccharide
priming for the ATP-induced release. Neither IL-1beta nor IL-18 release was prevented by ICE inhibition, and IL-18 release was not induced by ICE activation itself. Release of both cytokines was blocked completely by a P2X7 receptor antagonist, oxidized ATP, and partially by an antibody to
P2X
(7) receptor. In evaluating the signaling components involved in the ATP effect, we identified that the protein-tyrosine kinase inhibitor, AG126, produced a profound inhibition of both ICE activation as well as release of IL-1beta/IL-18. Taken together, these results suggest that, although synthesis of IL-1beta and IL-18 differ, ATP-mediated release of both cytokines requires a priming step but not proteolytically functional caspase-1.
...
PMID:ATP-stimulated release of interleukin (IL)-1beta and IL-18 requires priming by lipopolysaccharide and is independent of caspase-1 cleavage. 1105 57
Microglial cells in the healthy adult brain possess a characteristic ramified morphology with multiple branched processes, small somata and down-regulated inflammatory properties. In contrast, microglial cells isolated from new-born rat brain inevitably show a non-ramified amoeboid phenotype, which is observed in vivo after pathologic activation or during development. To identify factors that control microglial morphology we investigated the effects of purines alone or in combination with astrocyte-conditioned medium (ACM). Under optimized culture conditions postnatal rat microglial cells developed an amoeboid to ovoid phenotype. Addition of 0.6-1 mM ATP or adenosine induced the outgrowth of numerous processes after 2-3 days that could be observed also in the presence of ACM as previously reported. Culture in ACM plus ATP or adenosine yielded an optimized ramified phenotype. ATP or adenosine, but not ACM alone, also prevented the formation of a flat, amoeboid morphology induced by
lipopolysaccharide
(
LPS
); however, at 0.6-1 mM they did not reduce the initial
LPS
-induced activation of the transcription factor NF-kappaB. By using specific agonists or antagonists the morphological transformations could not be confined to a distinct
purinoreceptor
subtype, but appeared to be mediated by long-term presence of adenosine in the medium to which phosphorylated purines were rapidly hydrolyzed by microglial cells. Since ACM did not contain sufficient concentrations of ATP or adenosine, purines are not the only ramification-inducing factors present in ACM; however, they are a valuable tool to induce microglial ramification in vitro.
...
PMID:ATP and adenosine induce ramification of microglia in vitro. 1128 50
The mrf-1 gene has been isolated from microglia exposed to cultured cerebellar granule neurons undergoing apoptosis. We have shown that mrf-1 is upregulated in response to neuronal death and degeneration both in vitro and in vivo. However, the exact role of MRF-1 remains unknown. Here we show that MRF-1 is released from cultured rat microglia, and its release is greatly enhanced under inflammatory conditions. When microglia were treated with ATP, the amount of MRF-1 that was released increased 10-fold compared to the basal level of release. Enhanced MRF-1 release was induced within 10 min and peaked within 1 h; after approximately 4 h, the MRF-1 release had returned to normal. MRF-1 release was stimulated by 2-methyl-thio-ATP (five-fold) and a
P2X
(7) selective agonist, 2'- and 3'-O-(4-benzoylbenzoyl)-ATP (ten-fold). Moreover, the ATP-stimulated MRF-1 release was inhibited by a
P2X
(7) selective antagonist, oxidized ATP (oATP), and also under a Ca(2+)-free condition. These results indicate that the effects of ATP are dependent on Ca(2+) influx through
P2X
(7) receptors. MRF-1 release was enhanced by Ca(2+)-ionophore A23187 (sixfold), thapsigargin (threefold); however, it was not enhanced by glutamate or
lipopolysaccharide
. Moreover, a platelet-activating factor enhanced microglial MRF-1 release in a dose-dependent manner. We also showed that a conditioned medium from cerebellar granule neurons undergoing apoptosis markedly increased MRF-1 release from microglia; that effect was significantly inhibited by oATP. These results indicate that selective inflammatory stimulations, including ATP and PAF, enhance MRF-1 release from microglia through a Ca(2+)-dependent mechanism and suggest that MRF-1 may play a role in cell-cell interactions under inflammatory conditions.
...
PMID:Selective inflammatory stimulations enhance release of microglial response factor (MRF)-1 from cultured microglia. 1242 Mar 15
Microglial cells are the pathologic sensors in the brain. ATP released from damaged cells is a candidate for signalling neural injury to microglia. Moreover, ATP is an extracellular messenger for propagating astrocyte activity in the form of Ca2+ waves. To test for the functional expression of purinoreceptors in microglial cells we employed the patch-clamp technique in acute slices of adult mouse brain. ATP triggered a nonselective cationic and a K+ current. Pharmacological screening with purinergic ligands indicated the presence of P2Y1 and P2Y2/4 receptors linked to the activation of a K+ current and
P2X
receptors, including P2X7, linked to the activation of a nonselective cationic current. These findings suggest that microglial cells in situ express different purinergic receptors with distinct sensitivity and functional coupling. To test for the involvement of purinoreceptors in microglial activation, we stimulated cultured microglial cells with
lipopolysaccharide
and measured the release of tumour necrosis factor alpha, interleukin-6, interleukin-12 and macrophage inflammatory protein 1alpha, induction of K+ outward currents and nitric oxide release. All these parameters were reduced in the presence of purinergic ligands, indicating that purinergic receptor activation attenuated indicators of microglial activation.
...
PMID:Purinergic receptors on microglial cells: functional expression in acute brain slices and modulation of microglial activation in vitro. 1281 60
1
2
3
4
5
6
Next >>